Background illustration for clinical trials search

Influenza Clinical Trials

Browse 153 Influenza clinical trials enrolling across the United States and Canada. 50 people applied to Influenza studies last month. Search by city or state to find one near you.

Filter
1

Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

for
COVID -19, COVID - 19, COVID 19, Influenza, Respiratory Virus,
Location: Bethesda MD
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All

Age: 18 - 70+

Code: NCT07287137

Phase 4, Recruiting

Immune Defense Protein Impact On Respiratory Immune Outcomes

for
Upper Respiratory Disease, Influenza,
Location: Los Angeles CA
Sponsor: Quantec Ltd

Sex: All

Age: 60+

Code: NCT07431840

Recruiting

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

for
Respiratory Tract Infection, Smell Disorder, Influenza,
Location: Bethesda MD
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)

Sex: All

Age: 18 - 70+

Code: NCT07149428

Recruiting

Preparedness Through Respiratory Virus Epidemiology and Community Engagement

for
Respiratory Infection Virus, COVID -19, RSV, FLU
Location: San Ysidro CA, La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 0+

Code: NCT07147517

Recruiting

Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)

for
Influenza A, Influenza B, SAR-CoV-2,
Location: Toronto
Sponsor: Unity Health Toronto

Sex: All

Age: 18+

Code: NCT07314905

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

for
Influenza, Respiratory Virus, Coronavirus
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 65

Code: NCT04772170

Recruiting

Evaluation of the Safety and Pharmacokinetics of Oleander 4X in Healthy Volunteers

for
Flu-like Symptoms
Location: Roanoke VA
Sponsor: Avila Herbals

Sex: All

Age: 18 - 65

Code: NCT04674709

Phase 1, Recruiting

Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults

for
Influenza, Human
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT05108818

Recruiting

Cluster RCT - Evaluating Effectiveness of a Guide and Tools for Influenza Immunization Campaign Planners

for
Influenza
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT01207518

Recruiting

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

for
Hematopoietic and Lymphoid Cell Neoplasm, Influenza
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12+

Code: NCT04712539

Phase 2, Recruiting

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

for
COVID 19, Influenza, Rheumatoid Arthritis (RA),
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT06599658

Phase 2, Recruiting

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

for
Zika, Influenza
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 65

Code: NCT01386424

Recruiting

Respiratory Virus Sampling and Repository

for
Influenza, COVID-19
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3+

Code: NCT05266222

Recruiting

Influenza Immunization in Adults Over Age 75

for
Influenza, Immunization, Older Adults, Over Age 75
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 70+

Code: NCT02200276

Recruiting

A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients

for
Influenza a, Influenza B, RSV, COVID 19
Location: Pittsburgh PA, McAllen TX, Henderson NV
Sponsor: DiaSorin Molecular LLC

Sex: All

Age: 0+

Code: NCT06672692

Recruiting

Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness

for
Influenza (Healthy Volunteers)
Location: Halifax
Sponsor: Dalhousie University

Sex: All

Age: 18 - 45

Code: NCT07305207

Phase 1, Recruiting

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

for
Influenza, Community-acquired Pneumonia, Cardiovascular Events
Location: Oakland CA
Sponsor: Kaiser Permanente

Sex: All

Age: 65+

Code: NCT06029933

Recruiting

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

for
Influenza, Human+COVID-19
Location: Newport News VA, Charlottesville VA, West Palm Beach FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 65 - 70+

Code: NCT07464314

Phase 1, Recruiting

Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2

for
Influenza, SARS-CoV-2 (COVID-19) Infection,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18 - 60

Code: NCT06848309

Recruiting

BPL-1357 Against H1N1 Influenza Virus Challenge

for
Influenza, Human
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 55

Code: NCT07215858

Phase 2, Recruiting

What is influenza?

Influenza, or flu, is a contagious respiratory infection caused by influenza viruses that spread through coughs, sneezes, and contaminated surfaces. It comes on fast with fever, aches, cough, and exhaustion, and for most people passes within a week or two, but it sends hundreds of thousands of Americans to the hospital in a typical season and is most dangerous for people over 65, young children, pregnant women, and people with heart, lung, or immune conditions. Flu viruses change constantly, which is why the vaccine is reformulated every year and why protection from one season does not carry over to the next.

Antiviral medicines shorten the illness if started within the first two days, and vaccination remains the main way to prevent severe disease. The first mRNA flu vaccine was approved in 2026, and researchers are working toward a universal vaccine that would not need yearly updates. COVID-19 is studied separately on our COVID-19 clinical trials page.

Article preview image

Interested in learning more about flu treatment? Read our guide: Flu Symptoms, Treatment, and Vaccines Explained

Rethinking Influenza: What the Latest Research Shows

Types of influenza clinical trials

Do influenza clinical trials only happen during flu season?

Who can participate in influenza clinical trials?

Do influenza trial participants get paid?

How to enroll in an influenza clinical trial